Q/C Technologies, Inc. Cash Flow Conversion Efficiency
Q/C Technologies, Inc. cash flow conversion efficiency. Based on the latest financial reports, Q/C Technologies, Inc. (QCLS) has a cash flow conversion efficiency ratio of -0.139x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.29 Million) by net assets ($23.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Q/C Technologies, Inc. (2020–2025)
Cash flow conversion efficiency of Q/C Technologies, Inc. from 2020 to 2025. This chart illustrates how Q/C Technologies, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View QCLS share price today for real-time trading data and today's change.
Q/C Technologies, Inc. Cash Flow Conversion Ratio Explained
Q/C Technologies, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Q/C Technologies, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Q/C Technologies, Inc. ranked by their cash flow conversion efficiency. Also see Q/C Technologies, Inc. stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
REDSUN PROPERTIES GROUP
F:0RJ
|
N/A |
|
Vertu Motors Plc
LSE:VTU
|
0.044x |
|
MS INTERNATIONAL plc
LSE:MSI
|
-0.025x |
|
EMPYREAN ENERGY LS-002
F:E1E
|
N/A |
|
PreveCeutical Medical Inc
F:18H
|
0.070x |
|
Pembroke VCT PLC
LSE:PEMB
|
-0.009x |
|
ZW Data Action Technologies Inc
NASDAQ:CNET
|
-0.026x |
|
Whitemud Resources Inc
V:WMK
|
0.164x |
Annual Cash Flow Conversion Efficiency for Q/C Technologies, Inc. (2020–2025)
The table below shows the annual cash flow conversion efficiency of Q/C Technologies, Inc. from 2020 to 2025. Review QCLS FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $21.75 Million | $-9.07 Million | -0.417x | +31.66% |
| 2024-12-31 | $14.72 Million | $-8.98 Million | -0.610x | +39.99% |
| 2023-12-31 | $12.77 Million | $-12.98 Million | -1.016x | -21.70% |
| 2022-12-31 | $14.70 Million | $-12.27 Million | -0.835x | -1.17% |
| 2021-12-31 | $23.65 Million | $-19.52 Million | -0.825x | -136.38% |
| 2020-12-31 | $-5.26 Million | $-11.92 Million | 2.268x | -- |
About Q/C Technologies, Inc.
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, … Read more